ibrutinib,rituximab
abbvie,janssen
['ritux', 'imab ']
are we moving away from asct in mcl? will the results of the triangle study or risk adapted treatment based on mrd change the balance away from transplant in first line? #ash22 
hematologa en Fleming, lymphoma fan, mama de Luchi, un poco yogi y mucha acuarela!